Foy


Indications and Reactions:

Role Indications Reactions
Secondary
Pneumonia 27.1%
Immunosuppressant Drug Therapy 8.5%
Pneumonia Bacterial 6.8%
Bacterial Infection 5.9%
Disseminated Intravascular Coagulation 5.9%
Prophylaxis 5.1%
Malignant Melanoma 4.2%
Allogenic Bone Marrow Transplantation Therapy 3.4%
Blood Pressure Increased 3.4%
Extracorporeal Circulation 3.4%
Pancreatitis Acute 3.4%
Polyuria 3.4%
Renal Transplant 3.4%
Sedation 3.4%
Cholecystitis 2.5%
Hepatic Neoplasm Malignant 2.5%
Pancreatitis 2.5%
Angina Pectoris 1.7%
Multiple Myeloma 1.7%
Premedication 1.7%
Sepsis 18.5%
Renal Tubular Disorder 14.8%
Haemolytic Uraemic Syndrome 11.1%
Rash 11.1%
Vasculitis 7.4%
Bronchopneumonia 3.7%
Eosinophilia 3.7%
Granulocytopenia 3.7%
Liver Disorder 3.7%
Myocardial Infarction 3.7%
Oedema Peripheral 3.7%
Pancytopenia 3.7%
Red Blood Cell Count Decreased 3.7%
Staphylococcal Sepsis 3.7%
Urine Output Decreased 3.7%
Concomitant
Prophylaxis 17.5%
Drug Use For Unknown Indication 14.2%
Surgery 12.6%
Multiple Myeloma 9.2%
Disseminated Intravascular Coagulation 4.6%
Hypertension 4.1%
Abdominal Pain 4.1%
Medical Diet 4.0%
Nutritional Support 3.2%
Oesophagitis 3.2%
Product Used For Unknown Indication 2.8%
Pneumonia Aspiration 2.7%
Pneumonia 2.6%
Hepatic Neoplasm Malignant 2.4%
Prophylaxis Against Transplant Rejection 2.3%
Gastritis 2.2%
Immunosuppression 2.2%
Infection 2.1%
Cancer Pain 2.0%
Aplastic Anaemia 1.9%
Sepsis 13.3%
Rash 8.6%
Thrombocytopenia 7.0%
White Blood Cell Count Decreased 7.0%
Renal Failure Acute 6.3%
Rhabdomyolysis 5.5%
Pancytopenia 4.7%
Platelet Count Decreased 4.7%
Renal Impairment 4.7%
White Blood Cell Count Increased 4.7%
Abdominal Pain 3.9%
Interstitial Lung Disease 3.9%
Liver Disorder 3.9%
Pancreatitis 3.9%
Respiratory Failure 3.9%
Hepatic Failure 3.1%
Hepatic Function Abnormal 3.1%
Pyrexia 3.1%
Death 2.3%
Disseminated Intravascular Coagulation 2.3%

Drug Data